Two Sigma Investments’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,186
Closed -$93.2K 3298
2024
Q4
$93.2K Buy
9,186
+3,457
+60% +$35.1K ﹤0.01% 2913
2024
Q3
$71.3K Buy
5,729
+4,805
+520% +$59.8K ﹤0.01% 2868
2024
Q2
$12K Buy
924
+11
+1% +$143 ﹤0.01% 2876
2024
Q1
$20.7K Sell
913
-8,572
-90% -$194K ﹤0.01% 2852
2023
Q4
$123K Buy
+9,485
New +$123K ﹤0.01% 2833
2023
Q3
Sell
-23,170
Closed -$622K 3014
2023
Q2
$622K Buy
+23,170
New +$622K ﹤0.01% 2152
2023
Q1
Sell
-17,687
Closed -$902K 3015
2022
Q4
$902K Buy
17,687
+2,465
+16% +$126K ﹤0.01% 1686
2022
Q3
$1.25M Sell
15,222
-53,028
-78% -$4.34M ﹤0.01% 1323
2022
Q2
$4.62M Sell
68,250
-6,278
-8% -$425K 0.02% 779
2022
Q1
$8.24M Buy
74,528
+8,593
+13% +$950K 0.02% 665
2021
Q4
$6.36M Sell
65,935
-7,177
-10% -$692K 0.01% 820
2021
Q3
$6.38M Buy
73,112
+16,704
+30% +$1.46M 0.01% 782
2021
Q2
$8.73M Sell
56,408
-43,101
-43% -$6.67M 0.02% 698
2021
Q1
$15.7M Buy
99,509
+96,828
+3,612% +$15.3M 0.04% 443
2020
Q4
$622K Sell
2,681
-83,162
-97% -$19.3M ﹤0.01% 1517
2020
Q3
$18.8M Buy
85,843
+70,127
+446% +$15.4M 0.07% 278
2020
Q2
$4.47M Sell
15,716
-13,459
-46% -$3.82M 0.02% 576
2020
Q1
$8.41M Sell
29,175
-21,047
-42% -$6.06M 0.07% 243
2019
Q4
$14.4M Buy
50,222
+48,774
+3,368% +$14M 0.04% 412
2019
Q3
$209K Sell
1,448
-2,679
-65% -$387K ﹤0.01% 1737
2019
Q2
$371K Sell
4,127
-18,992
-82% -$1.71M ﹤0.01% 1688
2019
Q1
$2.03M Sell
23,119
-17,625
-43% -$1.54M 0.01% 1147
2018
Q4
$5.73M Buy
40,744
+14,147
+53% +$1.99M 0.02% 670
2018
Q3
$6.79M Sell
26,597
-7,057
-21% -$1.8M 0.02% 686
2018
Q2
$8.58M Buy
33,654
+25,528
+314% +$6.51M 0.03% 572
2018
Q1
$1.64M Buy
8,126
+6,511
+403% +$1.31M 0.01% 1132
2017
Q4
$233K Buy
1,615
+702
+77% +$101K ﹤0.01% 1995
2017
Q3
$150K Buy
+913
New +$150K ﹤0.01% 1810